Non-steroidal anti-inflammatory use and miscarriage

非甾体抗炎药的使用和流产

基本信息

批准号：
7496629
负责人：
KATHERINE E HARTMANN
金额：
$ 52.05万
依托单位：
VANDERBILT UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2006
资助国家：
美国
起止时间：
2006-05-01 至 2011-02-28
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7496629
关键词：
Address Adverse effects Age Analgesics Anti-Inflammatory Agents Anti-inflammatory Birth Caring Clinical Cohort Studies Communities Computer Assisted Conceptions County Daily Data Data Collection Development Disinfection Dose Drug Exposure Drug usage Enrollment First Pregnancy Trimester G-Banding Goals Health Heart Rate Hemorrhage Hospitals Internet Interview Karyotype determination procedure Literature Medical Records Methods Natural History Non-Steroidal Anti-Inflammatory Agents North Carolina Outcome Participant Patient currently pregnant Pharmaceutical Preparations Phase Pregnancy Pregnancy Outcome Protocols documentation Public Health Quality Control RQ2 Recruitment Activity Relative Risks Research Research Infrastructure Risk Safety Sampling Specimen Spontaneous abortion Staging Standards of Weights and Measures Symptoms System Telephone Telephone Interviews Time Tissues Ultrasonography United States Uterine Fibroids Water Week Woman abstracting base comparative genomic hybridization data management diaries experience fetal implantation prospective reproductive tool

项目摘要

DESCRIPTION (provided by applicant): Thirty-nine percent of reproductive age women have used a non-steroidal anti-inflammatory drug (NSAID) in the past week, and NSAIDs are the most frequent medication exposure in the first trimester of pregnancy. The safety of NSAID use in early pregnancy is uncertain. Our objective is to examine prospectively the association of NSAID use with spontaneous abortion. We propose to enroll women who are planning a pregnancy and obtain daily diaries of medication use, symptoms (indications) and other key confounders during the period while participants are attempting to conceive. Among the first 1,200 women who become pregnant, we will continue to collect daily diary information through the 12th week of pregnancy, obtain an early pregnancy ultrasound in the sixth week, and conduct an extensive computer assisted telephone interview at 13 weeks. Birth outcomes will be documented for all pregnancies and karyotyping will be done on all losses where a tissue specimen is available. These methods will allow us to answer our primary research questions: (1) Is NSAID use independently associated with increased risk of spontaneous abortion? (2) Does the association of NSAIDs with spontaneous abortion depend on cumulative dose, regular versus episodic use, and/or exposure during critical developmental windows? and these secondary questions: (3) Are common indications for NSAID use independently associated with spontaneous abortion? (4) Does developmental stage attained prior to spontaneous abortion differ between exposed and unexposed pregnancies? The primary tools for the proposed study are already in place including successful approaches to community-based recruitment prior to pregnancy, ultrasound forms and protocols, computer assisted telephone interviews, data management and quality control systems and experienced staff. Costly piloting and implementation phases have been completed. In short, we are fully prepared to efficiently address pressing questions about NSAID exposure in early pregnancy by conducting a large-scale, fully-prospective cohort study. If NSAID use has an adverse effect on early pregnancy outcomes, the public health impact would be substantial. For example, if NSAID exposure increases relative risk by 50 per cent, and 19 per cent of women use NSAIDs during the first trimester of pregnancy (a conservative estimate based on retrospective data), then over 80,000 spontaneous abortions could be attributed to NSAIDs each year in the United States.

描述（由申请人提供）：39% 的育龄妇女在过去一周使用过非甾体类抗炎药 (NSAID)，而 NSAID 是妊娠前三个月最常见的药物暴露。妊娠早期使用非甾体抗炎药的安全性尚不确定。我们的目标是前瞻性地研究非甾体抗炎药的使用与自然流产的关联。我们建议招募计划怀孕的女性，并获取参与者尝试怀孕期间的药物使用情况、症状（适应症）和其他关键混杂因素的每日日记。在首批怀孕的 1,200 名女性中，我们将继续收集怀孕第 12 周的每日日记信息，在第 6 周进行早孕超声检查，并在第 13 周进行广泛的计算机辅助电话访谈。将记录所有怀孕的出生结果，并在有组织样本的情况下对所有损失进行核型分析。这些方法将使我们能够回答我们的主要研究问题：（1）非甾体抗炎药的使用是否与自然流产风险增加独立相关？ (2) NSAIDs 与自然流产的关联是否取决于累积剂量、定期使用与偶尔使用和/或关键发育窗口期间的暴露？以及这些次要问题：（3）使用 NSAID 的常见适应症是否与自然流产独立相关？ (4) 暴露妊娠和未暴露妊娠在自然流产之前达到的发育阶段是否不同？拟议研究的主要工具已经到位，包括怀孕前社区招募的成功方法、超声表格和方案、计算机辅助电话访谈、数据管理和质量控制系统以及经验丰富的工作人员。成本高昂的试点和实施阶段已经完成。简而言之，我们已做好充分准备，通过开展大规模、完全前瞻性的队列研究，有效解决有关妊娠早期 NSAID 暴露的紧迫问题。如果非甾体抗炎药的使用对早期妊娠结局产生不利影响，那么对公共健康的影响将是巨大的。例如，如果接触 NSAID 会使相对风险增加 50%，并且 19% 的女性在怀孕的前三个月使用 NSAID（基于回顾性数据的保守估计），那么每年有超过 80,000 例自然流产可能归因于 NSAID在美国。